Method of intra-operative coating therapeutic agents onto sutures composite sutures and methods of use
Intra-operative coating of sutures with therapeutic proteins, particularly growth factors such as rhGDF-5. including contacting a suture to a device containing a therapeutic agent, methods of repairing soft tissue defects with coated sutures and composite sutures coated with therapeutic agents.
1 . A method of repairing a soft tissue defect, comprising the steps of:
a) providing a defect in a soft tissue selected from the group consisting of a ligament, a meniscus, an annulus fibrosus of an intervertebral disc, and a rotator cuff, and
b) advancing a suture coated with a therapeutic agent through the defect.
2 . The method of claim 1 wherein the therapeutic agent is a growth factor.
3 . The method of claim 1 wherein the therapeutic agent is within a TGF-β superfamily.
4 . The method of claim 1 wherein the therapeutic agent is a BMP.
5 . The method of claim 1 wherein the therapeutic agent is a BMP-2.
6 . The method of claim 1 wherein the therapeutic agent is a BMP-7.
7 . The method of claim 1 wherein the therapeutic agent is butyric acid.
8 . The method of claim 1 wherein the therapeutic agent is GDF-5.
9 . The method of claim 1 wherein the therapeutic agent is OP-1.
10 . The method of claim 1 wherein the therapeutic agent is VEGF.
11 . The method of claim 1 wherein the therapeutic agent is PDGF.
12 . The method of claim 1 wherein the defect is an anterior cruciate ligament defect.
13 . The method of claim 12 wherein the therapeutic agent is a growth factor.
14 . The method of claim 12 wherein the growth factor is GDF-5.
15 . The method of claim 1 wherein the defect is a medial collateral ligament defect.
16 . The method of claim 15 wherein the therapeutic agent is a growth factor.
17 . The method of claim 15 wherein the growth factor is GDF-5.
18 . The method of claim 1 wherein the defect is a meniscal defect.
19 . The method of claim 18 wherein the therapeutic agent is a growth factor.
20 . The method of claim 18 wherein the growth factor is GDF-5.
21 . The method of claim 1 wherein the defect is a rotator cuff defect.
22 . The method of claim 21 wherein the therapeutic agent is a growth factor.
23 . The method of claim 21 wherein the growth factor is GDF-5.
24 . The method of claim 1 wherein the soft tissue is an annulus fibrosus of an intervertebral disc.
25 . The method of claim 24 wherein the therapeutic agent is a growth factor.
26 . The method of claim 24 wherein the growth factor is GDF-5.
27 . The method of claim 1 wherein the soft tissue is a ligament.
28 . The method of claim 27 wherein the therapeutic agent is a growth factor.
29 . The method of claim 27 wherein the growth factor is GDF-5.
30 . A method of repairing a soft tissue defect, comprising the steps of:
a) providing a defect in an Achilles tendon, and
b) advancing a suture coated with a therapeutic agent through the defect,
wherein the therapeutic agent is selected from the group consisting of BMP-2, BMP-7, butyric acid, OP-1, VEGF and PDGF.
31 . The method of claim 30 wherein the therapeutic agent is a BMP-2.
32 . The method of claim 30 wherein the therapeutic agent is a BMP-7.
33 . The method of claim 30 wherein the therapeutic agent is butyric acid.
34 . The method of claim 30 wherein the therapeutic agent is OP-1.
35 . The method of claim 30 wherein the therapeutic agent is VEGF.
36 . The method of claim 30 wherein the therapeutic agent is PDGF.